Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CinBiCarn: Prevention of Contrast-Induced Nephropathy
NCT01786824Phase 3Terminated
- Sponsor
- CHU Nîmes
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of levocarnitine, sodium bicarbonate ringer's solution in contrast-induced nephropathy (CIN), sponsored by CHU Nîmes. Started Dec 2014; status: terminated.
02
Drugs
levocarnitinesodium bicarbonate ringer's solution
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01786824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786824.